These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 4847668)

  • 1. Tranexamic acid and fibrinolytic activity of the vessel wall.
    Astedt B; Liedholm P
    Experientia; 1974 Jul; 30(7):776-7. PubMed ID: 4847668
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative assessment of fibrinolysis on isolated glomeruli.
    Sraer JD; Boelaert J; Mimoune O; Morel-Maroger L; Hornych H
    Kidney Int; 1973 Nov; 4(5):350-2. PubMed ID: 4762582
    [No Abstract]   [Full Text] [Related]  

  • 3. Biphasic inhibition of urokinase-induced fibrinolysis by epsilon-aminocaproic acid; distinction from tissue plasminogen activator.
    Thorsen S; Astrup T
    Proc Soc Exp Biol Med; 1969 Mar; 130(3):811-3. PubMed ID: 5773672
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthetic inhibitors of fibrinolysis: in vitro and in vivo mode of action.
    Okamoto S; Oshiba S; Mihara H; Okamoto U
    Ann N Y Acad Sci; 1968 Jun; 146(2):414-29. PubMed ID: 5254270
    [No Abstract]   [Full Text] [Related]  

  • 5. A light and electron microscopic study of arteries and other tissues from dogs subjected to chronic fibrinolytic inhibition with AMCHA.
    Steenblock DA; Celander DR
    Vasc Surg; 1968 Sep; 2(3):149-56. PubMed ID: 5759058
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of tranexamic acid, cis-AMCHA, and 6-aminohexanoic acid on the activation rate of plasminogen by urokinase in the presence of clot.
    Takada A; Ohashi H; Matsuda H; Takada Y
    Thromb Res; 1979; 14(6):915-23. PubMed ID: 473126
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on the mechanism of action of synthetic antifibrinolytics. A comparison with the action of derivatives of benzamidine on the fibrinolytic process.
    Landmann H
    Thromb Diath Haemorrh; 1973 May; 29(2):253-75. PubMed ID: 4271586
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of trans-4-aminomethylcyclohexane carboxylic acid as an antifibrinolytic agent on arterial wall and experimental atherosclerotic lesions in rabbits.
    Kato N; Morimatsu M; Tanaka K; Horie A
    Thromb Diath Haemorrh; 1970 Oct; 24(1):85-99. PubMed ID: 5483976
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of antifibrinolytic substances on allergic reactions. Experiments with epsilon-aminocaproic acid and amino-methyl-cyclohexane-carbonic acid.
    Raab W
    Experientia; 1968 Mar; 24(3):250. PubMed ID: 5661420
    [No Abstract]   [Full Text] [Related]  

  • 10. Medicinal chemical studies on antiplasmin drugs. 4. Chemical modification of trans-4-aminomethylcyclohexanecarboxylic acid and its effect on antiplasmin activity.
    Okano A; Inaoka M; Funabashi S; Iwamoto M; Isoda S
    J Med Chem; 1972 Mar; 15(3):247-55. PubMed ID: 5059209
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemical control of hyperfibrinolytic states by synthetic inhibitors of fibrinolytic enzymes.
    Markwardt F; Klöcking HP
    Biomed Biochim Acta; 1983; 42(6):725-30. PubMed ID: 6605748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some properties of the tissue plasminogen activator from the pig heart.
    Hijikata A; Fujimoto K; Kitaguchi H; Okamoto S
    Thromb Res; 1974 Jun; 4(6):731-40. PubMed ID: 4844057
    [No Abstract]   [Full Text] [Related]  

  • 13. Experimental studies on the production of pulmonary infarction. IV. Effects of UK, heparin, t-AMCHA or ellagic acid.
    Hasegawa H; Watanabe N; Kakizaki H; Murata H
    Jpn Heart J; 1973 Jul; 14(4):335-49. PubMed ID: 4542948
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of urokinase and tissue activator in sustaining bleeding and the management thereof with EACA and AMCA.
    Andersson L; Nilsoon IM; Colleen S; Granstrand B; Melander B
    Ann N Y Acad Sci; 1968 Jun; 146(2):642-58. PubMed ID: 5254275
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention of vessel wall damage in experimental irradiation.
    Smit Sibinga CT
    Bibl Anat; 1973; 12():242-8. PubMed ID: 4275205
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on the mechanism of action of inhibitors of the fibrinolysin system.
    Ambrus CM; Ambrus JL; Lassman HB; Mink IB
    Ann N Y Acad Sci; 1968 Jun; 146(2):430-47. PubMed ID: 4239437
    [No Abstract]   [Full Text] [Related]  

  • 17. Desmoteplase-mediated plasminogen activation and clot lysis are inhibited by the lysine analogue tranexamic acid.
    Niego B; Horvath A; Coughlin PB; Pugsley MK; Medcalf RL
    Blood Coagul Fibrinolysis; 2008 Jun; 19(4):322-4. PubMed ID: 18469556
    [No Abstract]   [Full Text] [Related]  

  • 18. [Tranexamic acid, a new antifibrinolytic agent].
    Kjellman H; Schannong M
    Nord Med; 1970 Feb; 83(6):166-8. PubMed ID: 4910677
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the effect of a new synthetic inhibitor of the fibrinolytic system].
    Fischer M; Pavlu C
    Arzneimittelforschung; 1966 May; 16(5):671-3. PubMed ID: 6014440
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on the fibrinolytic activity in human semen studied by gel filtration.
    Hisazumi H
    Invest Urol; 1970 Mar; 7(5):410-21. PubMed ID: 5461871
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.